SCING—Spinal Cord Injury Neuroprotection with Glyburide: a pilot, open-label, multicentre, prospective evaluation of oral glyburide in patients with acute traumatic spinal cord injury in the USA

INTRODUCTION: Acute traumatic spinal cord injury (tSCI) is a devastating neurological disorder with no pharmacological neuroprotective strategy proven effective to date. Progressive haemorrhagic necrosis (PHN) represents an increasingly well-characterised mechanism of secondary injury after tSCI tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Minnema, Amy Janelle, Mehta, A, Boling, Warren W, Schwab, Jan, Simard, J Marc, Farhadi, H Francis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797422/
https://www.ncbi.nlm.nih.gov/pubmed/31601596
http://dx.doi.org/10.1136/bmjopen-2019-031329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797422/
https://www.ncbi.nlm.nih.gov/pubmed/31601596
http://dx.doi.org/10.1136/bmjopen-2019-031329

Ejemplares similares